Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cortex Pharmaceuticals Inc

+ Add to Watchlist

PHX:GR

0.042 EUR 0.001 2.33%

As of 02:16:04 ET on 05/28/2015.

Snapshot for Cortex Pharmaceuticals Inc (PHX)

Open: 0.042 Day's Range: 0.042 - 0.042 Volume: 0
Previous Close: 0.043 52wk Range: 0.020 - 0.063 1-Yr Rtn: +31.25%

Stock Chart for PHX

No chart data available.
  • PHX:GR 0.042
  • 1D
  • 1M
  • 1Y
0.043
Interactive PHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 15.83
Shares Outstanding (M) 376.83
30 Day Average Volume 1
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 06/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PHX

Cortex Pharmaceuticals, Inc. discovers, develops, and commercializes pharmaceuticals for the treatment of neurodegenerative diseases and other neurological and psychiatric disorders. The Company develops a family of chemical compounds, known as Ampakines, that enhance the activity of the AMPA-type glutamate receptor.

Mark A VarneyPresident/CEORobert N WeingartenVP/CFO
More Company Profile & Key Executives for PHX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil